Navigation Links
Centice Corporation Enhances the PASS Rx System with its Version 3.0 Software Update
Date:2/1/2010

Centice Corporation, a pioneer in drug verification and safety products, announced today that it has released a new version of its PASS Rx system.

Morrisville, NC (PRWEB) February 1, 2010 -- Centice Corporation, a pioneer in drug verification and safety products, announced today that it has released a new version of its PASS Rx system. PASS Rx scientifically verifies, within a closed pill vial, the majority of the oral solid medications to improve the dispense accuracy in pharmacies. PASS Rx is the most reliable solution to allow pharmacies to protect themselves and their patients.

According to a 2006 report from the Institute of Medicine, at least 1.5 million Americans are injured by medication errors every year, many due to the wrong drug or strength being dispensed. Another study states that about four drug or strength errors occur per day in a pharmacy with a daily volume of 250 prescriptions. Manual verification can be largely subjective; Centice can help.

The new enhancements in Version 3.0 include an increased database size to over two thousand unique medications, which equates to more than 20,000 NDCs. In addition, PASS Rx can now be used to perform accuracy scans for barcode-based verification of non-vial dispensed drugs. Combined, these enhancements enable PASS Rx to cover nearly 100% of the workflow in retail and hospital outpatient pharmacies.

After multiple customer focus groups were conducted, the new user interface was also improved to provide the pharmacist or technician with easy to understand results on the display. The user interface continues to provide Medi-Span® drug images and descriptions for the added value of visual verification.

Centice Corporation provides its customers with storage and reporting capabilities
'/>"/>

Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved  

Page: 1 2

Related medicine news :

1. Providence Service Corporation to Present at the Jefferies 2010 Global Healthcare Services Conference on Monday, January 25th
2. Centage Corporation Reports 16% Growth in 2009; Planning Maestro, Business Performance Management Software Implementations on the Rise
3. Hepregen Corporation Receives SBIR Phase II Grant from the National Science Foundation and Presents Corporate Update at OneMed Forum
4. United American Healthcare Corporation Announces Meeting Date and Record Date for Annual Meeting of Shareholders
5. Amerigroup Corporation to Discuss Fourth Quarter and 2009 Year-End Earnings on February 19
6. Providence Service Corporation Comments on Senate Health Care Reform
7. Triple-S Management Corporation to Present at J. P. Morgan Healthcare Conference
8. Service Corporation International Extends Offer for Keystone North America Inc.
9. Atrion Networking Corporation Selects Ruckus Wireless for Reliable as Wire Enterprise Wi-Fi Service
10. Corporations, Universities and State Governments Deploy Thomson Reuters Solution to Improve Employees Benefit Selection Process
11. China Cord Blood Corporation Announces Results for the Quarter and Six Months Ended September 30, 2009
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Centice Corporation Enhances the PASS Rx System with its Version 3.0 Software Update  
(Date:8/4/2015)... ... August 04, 2015 , ... Healthcare ... executives and technology professionals in healthcare and technology markets, today announced significant spikes ... of Defense’s recently-announced Electronic Health Record (EHR) decision. The DOD related numbers solidify ...
(Date:8/3/2015)... ... ... of the economic recovery since the 2008 has been subject to much debate, the fact ... six years. Unemployment has dropped from a 2009 high of 10 percent to 5.9 percent, ... the U.S. stock market is at an all time high, and interest rates at near ...
(Date:8/3/2015)... ... August 04, 2015 , ... The American ... , The new internationally peer-reviewed Guidelines were prepared by members of the AAT ... imaging, in evaluating patients with dental-oral and systemic health-related complaints. , Thermography ...
(Date:8/3/2015)... ... , ... Sutter Health’s California Pacific Medical center announces the appointment of Hamila ... in her role effective immediately and will have responsibility for all aspects of operations ... Health for about 15 years, including the past 7 years as vice president of ...
(Date:8/3/2015)... Mich (PRWEB) , ... August 03, 2015 , ... Since ... country has declined, according to a new publication released today by the AAMC (Association ... black male college graduates over the past three decades, the number of black male ...
Breaking Medicine News(10 mins):Health News:Coverage of DOD’s EHR Decision Reinforces Healthcare IT News’ Leadership 2Health News:Newport Board group, an Advisory Firm Serving the Middle Market, Cautions Businesses on How to Survive the Coming Recession 2Health News:Newport Board group, an Advisory Firm Serving the Middle Market, Cautions Businesses on How to Survive the Coming Recession 3Health News:Newport Board group, an Advisory Firm Serving the Middle Market, Cautions Businesses on How to Survive the Coming Recession 4Health News:American Academy of Thermology (AAT) Publishes First-Ever Guidelines for Oral-Systemic Thermography 2Health News:American Academy of Thermology (AAT) Publishes First-Ever Guidelines for Oral-Systemic Thermography 3Health News:Hamila Kownacki, RN Appointed as New Chief Operating Officer at CPMC 2Health News:New Publication Focuses on the Decline of Black Males in Medicine 2Health News:New Publication Focuses on the Decline of Black Males in Medicine 3Health News:New Publication Focuses on the Decline of Black Males in Medicine 4
... to identify the agricultural areas with the greatest potential for ... ), which is at risk of extinction. The study shows ... Park of the Sierra de Cardea y Montoro, in Crdoba ... this species lives are the most appropriate sites ...
... , , , ... Healthcare, one of the nation,s first and leading providers of kidney ... the recipients of the 2009 Norman S. Coplon Extramural Grant Program. ... and medical centers in the United States and Canada who are ...
... , , , SAN DIEGO, ... company, today announced that the U.S. Court of Appeals for the ... over the validity of its patents that cover the methods for ... thiopurines to reach and maintain desired therapeutic levels (U.S. Patent Nos. ...
... , , Stable Medicare ... Quality Report , , WASHINGTON, Sept. ... Alliance for Quality Nursing Home Care (Alliance) characterized the health care ... as a step in the right direction, and said the process ...
... , WASHINGTON, Sept. 17 More than ... joint Open Letter to Congress declaring that the health care ... act now on meaningful reforms. They state that Congress has a ... , , The Open Letter identifies eight ...
... , , , ... advanced medical and aesthetic devices, introduces Smooth Cool HR/SR, a world-class ... the light based hair removal market. Smooth Cool HR/SR will make ... first thru third. "Smooth Cool HR/SR is designed for the practitioner ...
Cached Medicine News:Health News:Proposal to reintroduce Iberian lynx on abandoned agricultural land 2Health News:Satellite Healthcare Announces the Recipients of the 2009 Norman S. Coplon Extramural Grants 2Health News:Satellite Healthcare Announces the Recipients of the 2009 Norman S. Coplon Extramural Grants 3Health News:Appeals Court Rules in Favor of Prometheus, Upholds the Patentability of Its Claims for Methods of Thiopurine Metabolite Testing 2Health News:Baucus Approach to Financing Health Care Reform Step in Right Direction 2Health News:Leading American Healthcare Experts Press Congress to Act Quickly on Health Reform 2Health News:Leading American Healthcare Experts Press Congress to Act Quickly on Health Reform 3Health News:Leading American Healthcare Experts Press Congress to Act Quickly on Health Reform 4Health News:Eclipse Introduces Smooth Cool HR/SR with Unique Chilling Technology 2
(Date:8/3/2015)... BOULDER, Colo., Aug. 3, 2015  Array BioPharma ... for the fourth quarter and full year of ... Ron Squarer, Chief Executive Officer of Array, noted, ... Phase 3, are on track for regulatory submissions ... in BRAF-mutant melanoma and BRAF-mutant colorectal cancer further ...
(Date:8/3/2015)... Aug. 3, 2015  Charleston Laboratories, Inc., an ... second clinical development program with a Phase 1 ... CL-H1T contains fast-dissolving promethazine and sumatriptan.  ... a treatment for migraine headache pain and migraine-induced ... patients with migraine headaches also suffer from nausea ...
(Date:8/3/2015)... FLORHAM PARK, N.J. , Aug. 3, ... met its primary and secondary endpoints in a phase ... constipation (OIC) in adult patients with chronic non-cancer pain. ... antagonist (PAMORA). This is the third Phase III trial ... endpoints. Study results showed that a 0.2 ...
Breaking Medicine Technology:Array BioPharma Reports Financial Results For The Fourth Quarter And Full Year Of Fiscal 2015 2Array BioPharma Reports Financial Results For The Fourth Quarter And Full Year Of Fiscal 2015 3Array BioPharma Reports Financial Results For The Fourth Quarter And Full Year Of Fiscal 2015 4Array BioPharma Reports Financial Results For The Fourth Quarter And Full Year Of Fiscal 2015 5Array BioPharma Reports Financial Results For The Fourth Quarter And Full Year Of Fiscal 2015 6Array BioPharma Reports Financial Results For The Fourth Quarter And Full Year Of Fiscal 2015 7Array BioPharma Reports Financial Results For The Fourth Quarter And Full Year Of Fiscal 2015 8Array BioPharma Reports Financial Results For The Fourth Quarter And Full Year Of Fiscal 2015 9Array BioPharma Reports Financial Results For The Fourth Quarter And Full Year Of Fiscal 2015 10Array BioPharma Reports Financial Results For The Fourth Quarter And Full Year Of Fiscal 2015 11Array BioPharma Reports Financial Results For The Fourth Quarter And Full Year Of Fiscal 2015 12Charleston Laboratories, Inc. Initiates Patient Enrollment in a Phase 1 Study of Charleston's Second Product, CL-H1T 2Naldemedine Meets Primary Endpoint In Phase 3 Study For The Treatment Of Opioid-Induced Constipation 2Naldemedine Meets Primary Endpoint In Phase 3 Study For The Treatment Of Opioid-Induced Constipation 3Naldemedine Meets Primary Endpoint In Phase 3 Study For The Treatment Of Opioid-Induced Constipation 4
... SenSage, Inc., a leading provider of ... that it has been selected as Cerner Corporation,s (Nasdaq: ... for its ability to demonstrate significant speed to value ... announced today an expanded alliance with Cerner to offer ...
... Codexis, Inc. (Nasdaq: CDXS ) ... with Teva Pharmaceutical Industries Ltd., the world,s largest ... technology transfer of custom biocatalysts for manufacture of ... have been transferred to pilot manufacturing and a ...
Cached Medicine Technology:SenSage Named Cerner Corporation's 'Accelerate Partner of the Year' 2SenSage Named Cerner Corporation's 'Accelerate Partner of the Year' 3SenSage Named Cerner Corporation's 'Accelerate Partner of the Year' 4Codexis Achieves Development Milestones With Teva 2
CO 2 SMO-Capnograph/Pulse Oximeter...
A software program for simple, efficient pulse oximetry analysis, which enables easy viewing, analysis and report generation for pulse rate and SpO 2 ....
... the next generation in pulse oximetry monitoring ... current family of "digital pulse oximeters, MARSpO ... breakthroughs in signal processing. This provides improved ... superior performance during challenging clinical conditions such ...
The NPB-40 Handheld Pulse Oximeter is both compact and affordable. It is simple to operate, provides spot-check monitoring of SpO 2 and pulse rate, and is compact enough to fit in your pocket....
Medicine Products: